Carta ao Editor – “Recomendações na Abordagem do Doente com Hidradenite Supurativa”: A Importância da Colaboração com Doenças Infeciosas

João Matos; Isabel Furtado; Tiago Torres; António Ludgero Vasconcelos; Miguel Araújo Abreu

doi:10.20344/amp.20788

Letter to the Editor – “Guidelines for Management of Patients with Hidradenitis Suppurativa”: The Importance of Collaboration with Infectious Diseases

Authors

João Matos Serviço de Doenças Infeciosas. Centro Hospitalar Universitário de Santo António. Porto. https://orcid.org/0009-0001-8085-5142
Isabel Furtado Serviço de Doenças Infeciosas. Centro Hospitalar Universitário de Santo António. Porto.
Tiago Torres Serviço de Dermatologia. Centro Hospitalar Universitário de Santo António. Porto
António Ludgero Vasconcelos Serviço de Doenças Infeciosas. Centro Hospitalar Universitário de Santo António. Porto.
Miguel Araújo Abreu Serviço de Doenças Infeciosas. Centro Hospitalar Universitário de Santo António. Porto.

DOI:

https://doi.org/10.20344/amp.20788

Keywords:

Hidradenitis Suppurativa/diagnosis, Hidradenitis Suppurativa/surgery, Hidradenitis Suppurativa/therapy

Abstract

N/a.

Downloads

Download data is not yet available.

References

Cabete J, Aparício Martins I, Recomendações na abordagem do doente com hidradenite supurativa. Acta Med Port. 2023;36:133-9. DOI: https://doi.org/10.20344/amp.18916

Zouboulis CC, Desai N, Emtestam L, Hunger RE, Ioannides D, Juhász I, et al. European S1 guideline for the treatment of hidradenitis suppurativa/ acne inversa. J Eur Acad Dermatol Venereol. 2015;29:619-44. DOI: https://doi.org/10.1111/jdv.12966

Baddley JW, Cantini F, Goletti D, Gómez-Reino JJ, Mylonakis E, San-Juan R, et al. ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble immune effector molecules [I]: antitumor necrosis factor-α agents). Clin Microbiol Infect. 2018;24:S10-20. DOI: https://doi.org/10.1016/j.cmi.2017.12.025

Valdoleiros SR, Furtado I, Silva C, Correia Gonçalves I, Santos Silva A, Vasconcelos O, et al. Prevençã o e tratamento de infeçõ es na terapêutica de doenças autoimunes. Acta Med Port. 2021;34:469-83. DOI: https://doi.org/10.20344/amp.15625

Reinwald M, Silva JT, Mueller NJ, Fortún J, Garzoni C, de Fijter JW, et al. ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Intracellular signaling pathways: tyrosine kinase and mTOR inhibitors). Clin Microbiol Infect. 2018;24:S53-70. DOI: https://doi.org/10.1016/j.cmi.2018.02.009

Downloads

PDF (Português)

Published

2024-02-16

How to Cite

Matos J, Furtado I, Torres T, Vasconcelos AL, Araújo Abreu M. Letter to the Editor – “Guidelines for Management of Patients with Hidradenitis Suppurativa”: The Importance of Collaboration with Infectious Diseases. Acta Med Port [Internet]. 2024 Feb. 16 [cited 2024 Nov. 21];37(3):231-2. Available from: https://actamedicaportuguesa.com/revista/index.php/amp/article/view/20788

Download Citation

Issue

Vol. 37 No. 3 (2024): March

Section

Letters to the Editor

License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

All the articles published in the AMP are open access and comply with the requirements of funding agencies or academic institutions. The AMP is governed by the terms of the Creative Commons ‘Attribution – Non-Commercial Use - (CC-BY-NC)’ license, regarding the use by third parties.

It is the author’s responsibility to obtain approval for the reproduction of figures, tables, etc. from other publications.

Upon acceptance of an article for publication, the authors will be asked to complete the ICMJE “Copyright Liability and Copyright Sharing Statement “(http://www.actamedicaportuguesa.com/info/AMP-NormasPublicacao.pdf) and the “Declaration of Potential Conflicts of Interest” (http:// www.icmje.org/conflicts-of-interest). An e-mail will be sent to the corresponding author to acknowledge receipt of the manuscript.

After publication, the authors are authorised to make their articles available in repositories of their institutions of origin, as long as they always mention where they were published and according to the Creative Commons license.